

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 6.58141340 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.24412116 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.98288619 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.52788663 |
| 5 | vocalization behavior (GO:0071625) | 4.40045201 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.30424787 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.27909722 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.17723799 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.09711049 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.06392707 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.04039977 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.93715555 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.88801187 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 3.85282501 |
| 15 | serotonin metabolic process (GO:0042428) | 3.81008793 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 3.80140851 |
| 17 | glutamate secretion (GO:0014047) | 3.76435259 |
| 18 | protein localization to synapse (GO:0035418) | 3.72728753 |
| 19 | detection of calcium ion (GO:0005513) | 3.69484564 |
| 20 | indolalkylamine metabolic process (GO:0006586) | 3.68932175 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 3.68465871 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 3.64627892 |
| 23 | primary amino compound metabolic process (GO:1901160) | 3.62082645 |
| 24 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.58290530 |
| 25 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.57327332 |
| 26 | neuronal action potential propagation (GO:0019227) | 3.55750655 |
| 27 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46559768 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.45497930 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 3.44449715 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 3.43830485 |
| 31 | L-fucose catabolic process (GO:0042355) | 3.41766586 |
| 32 | fucose catabolic process (GO:0019317) | 3.41766586 |
| 33 | L-fucose metabolic process (GO:0042354) | 3.41766586 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 3.40037268 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.34677749 |
| 36 | long-term memory (GO:0007616) | 3.34087222 |
| 37 | chemosensory behavior (GO:0007635) | 3.30746690 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.29836399 |
| 39 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.29083140 |
| 40 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.25973006 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.25509473 |
| 42 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.22475341 |
| 43 | exploration behavior (GO:0035640) | 3.21576390 |
| 44 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.20530904 |
| 45 | synaptic vesicle endocytosis (GO:0048488) | 3.17388950 |
| 46 | positive regulation of membrane potential (GO:0045838) | 3.16266021 |
| 47 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.14736156 |
| 48 | tryptophan catabolic process (GO:0006569) | 3.14704446 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 3.14704446 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.14704446 |
| 51 | cellular potassium ion homeostasis (GO:0030007) | 3.14494093 |
| 52 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.14387813 |
| 53 | regulation of vesicle fusion (GO:0031338) | 3.12476517 |
| 54 | indole-containing compound metabolic process (GO:0042430) | 3.12273824 |
| 55 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.12245527 |
| 56 | neuron recognition (GO:0008038) | 3.11404270 |
| 57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.10045460 |
| 58 | kidney morphogenesis (GO:0060993) | 3.08297747 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.06673617 |
| 60 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.06150422 |
| 61 | presynaptic membrane assembly (GO:0097105) | 3.06001398 |
| 62 | kynurenine metabolic process (GO:0070189) | 3.05028445 |
| 63 | insulin secretion (GO:0030073) | 3.04643433 |
| 64 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.04525758 |
| 65 | parturition (GO:0007567) | 3.03103957 |
| 66 | regulation of mesoderm development (GO:2000380) | 2.98138867 |
| 67 | dendrite morphogenesis (GO:0048813) | 2.97996244 |
| 68 | * membrane depolarization during action potential (GO:0086010) | 2.96294162 |
| 69 | innervation (GO:0060384) | 2.96219342 |
| 70 | nephron epithelium morphogenesis (GO:0072088) | 2.93257258 |
| 71 | nephron tubule morphogenesis (GO:0072078) | 2.93257258 |
| 72 | startle response (GO:0001964) | 2.91547291 |
| 73 | layer formation in cerebral cortex (GO:0021819) | 2.91357748 |
| 74 | positive regulation of fatty acid oxidation (GO:0046321) | 2.89747048 |
| 75 | regulation of hippo signaling (GO:0035330) | 2.89651651 |
| 76 | activation of protein kinase A activity (GO:0034199) | 2.89580553 |
| 77 | neurotransmitter transport (GO:0006836) | 2.88349506 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 2.86655726 |
| 79 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.85005516 |
| 80 | postsynaptic membrane organization (GO:0001941) | 2.84827667 |
| 81 | regulation of neurotransmitter secretion (GO:0046928) | 2.84490654 |
| 82 | axonal fasciculation (GO:0007413) | 2.83937008 |
| 83 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.83498491 |
| 84 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.82620193 |
| 85 | * membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.80827315 |
| 86 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.80789152 |
| 87 | synapse assembly (GO:0007416) | 2.79751917 |
| 88 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.79628512 |
| 89 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.79467921 |
| 90 | positive regulation of exocytosis (GO:0045921) | 2.79206045 |
| 91 | long-term synaptic potentiation (GO:0060291) | 2.78800090 |
| 92 | dendritic spine organization (GO:0097061) | 2.78666165 |
| 93 | neuromuscular process controlling posture (GO:0050884) | 2.78361825 |
| 94 | cell proliferation in forebrain (GO:0021846) | 2.77269383 |
| 95 | positive regulation of synapse maturation (GO:0090129) | 2.76582541 |
| 96 | protein targeting to Golgi (GO:0000042) | 2.76442270 |
| 97 | presynaptic membrane organization (GO:0097090) | 2.76182750 |
| 98 | regulation of synaptic plasticity (GO:0048167) | 2.75336760 |
| 99 | axoneme assembly (GO:0035082) | 2.73994431 |
| 100 | regulation of exocytosis (GO:0017157) | 2.73692705 |
| 101 | epithelial cilium movement (GO:0003351) | 2.73356026 |
| 102 | * membrane depolarization (GO:0051899) | 2.73278173 |
| 103 | * calcium ion import (GO:0070509) | 2.72914212 |
| 104 | membrane hyperpolarization (GO:0060081) | 2.72788820 |
| 105 | cell communication by electrical coupling (GO:0010644) | 2.72583527 |
| 106 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.72237220 |
| 107 | neuronal ion channel clustering (GO:0045161) | 2.70731446 |
| 108 | spinal cord motor neuron differentiation (GO:0021522) | 2.70378075 |
| 109 | neuronal action potential (GO:0019228) | 2.69747040 |
| 110 | interkinetic nuclear migration (GO:0022027) | 2.68177041 |
| 111 | regulation of action potential (GO:0098900) | 2.67506783 |
| 112 | detection of light stimulus involved in visual perception (GO:0050908) | 2.67472225 |
| 113 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.67472225 |
| 114 | regulation of synapse structural plasticity (GO:0051823) | 2.66940893 |
| 115 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.66179799 |
| 116 | suckling behavior (GO:0001967) | 2.64603034 |
| 117 | sulfation (GO:0051923) | 2.64310563 |
| 118 | nonmotile primary cilium assembly (GO:0035058) | 2.64232012 |
| 119 | vesicle transport along microtubule (GO:0047496) | 2.63732853 |
| 120 | calcium ion-dependent exocytosis (GO:0017156) | 2.63283027 |
| 121 | proline transport (GO:0015824) | 2.62684230 |
| 122 | tryptophan metabolic process (GO:0006568) | 2.62158567 |
| 123 | cellular response to ATP (GO:0071318) | 2.61903496 |
| 124 | inner ear receptor cell development (GO:0060119) | 2.61724041 |
| 125 | protein polyglutamylation (GO:0018095) | 2.61432407 |
| 126 | regulation of neurotransmitter transport (GO:0051588) | 2.61431328 |
| 127 | negative regulation of hormone metabolic process (GO:0032351) | 2.61132015 |
| 128 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.61132015 |
| 129 | glycine transport (GO:0015816) | 2.60576560 |
| 130 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.60499607 |
| 131 | response to auditory stimulus (GO:0010996) | 2.60246463 |
| 132 | righting reflex (GO:0060013) | 2.59440194 |
| 133 | regulation of ARF protein signal transduction (GO:0032012) | 2.59291984 |
| 134 | negative regulation of appetite (GO:0032099) | 2.59140587 |
| 135 | negative regulation of response to food (GO:0032096) | 2.59140587 |
| 136 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.57717983 |
| 137 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.57708241 |
| 138 | regulation of neurotransmitter levels (GO:0001505) | 2.56244574 |
| 139 | reflex (GO:0060004) | 2.56163958 |
| 140 | cerebellar Purkinje cell layer development (GO:0021680) | 2.56151122 |
| 141 | nerve growth factor signaling pathway (GO:0038180) | 2.55892552 |
| 142 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.55251911 |
| 143 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.55083959 |
| 144 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.54960009 |
| 145 | positive regulation of vesicle fusion (GO:0031340) | 2.54801264 |
| 146 | cilium movement (GO:0003341) | 2.54021448 |
| 147 | action potential (GO:0001508) | 2.53038263 |
| 148 | cAMP catabolic process (GO:0006198) | 2.51913162 |
| 149 | ketone body metabolic process (GO:1902224) | 2.51566318 |
| 150 | endocrine pancreas development (GO:0031018) | 2.51092892 |
| 151 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.49408762 |
| 152 | synaptic transmission, cholinergic (GO:0007271) | 2.48420790 |
| 153 | regulation of neurotransmitter uptake (GO:0051580) | 2.47005728 |
| 154 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.46233618 |
| 155 | urinary tract smooth muscle contraction (GO:0014848) | 2.46133875 |
| 156 | response to pheromone (GO:0019236) | 2.43554204 |
| 157 | behavioral response to ethanol (GO:0048149) | 2.43104740 |
| 158 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.42697857 |
| 159 | appendage development (GO:0048736) | 2.41625826 |
| 160 | limb development (GO:0060173) | 2.41625826 |
| 161 | somite development (GO:0061053) | 2.39007008 |
| 162 | magnesium ion transport (GO:0015693) | 2.36581077 |
| 163 | cornea development in camera-type eye (GO:0061303) | 2.36132795 |
| 164 | protein localization to cilium (GO:0061512) | 2.35525130 |
| 165 | negative regulation of telomere maintenance (GO:0032205) | 2.35288856 |
| 166 | cyclic nucleotide catabolic process (GO:0009214) | 2.34615981 |
| 167 | dentate gyrus development (GO:0021542) | 2.34423798 |
| 168 | renal tubule morphogenesis (GO:0061333) | 2.33029528 |
| 169 | glycerophospholipid catabolic process (GO:0046475) | 2.32046790 |
| 170 | dopamine transport (GO:0015872) | 2.31755174 |
| 171 | DNA deamination (GO:0045006) | 2.31487785 |
| 172 | oxidative demethylation (GO:0070989) | 2.31292562 |
| 173 | behavioral defense response (GO:0002209) | 2.31003189 |
| 174 | behavioral fear response (GO:0001662) | 2.31003189 |
| 175 | adaptation of signaling pathway (GO:0023058) | 2.29948704 |
| 176 | endoderm formation (GO:0001706) | 2.29909885 |
| 177 | peristalsis (GO:0030432) | 2.29403168 |
| 178 | neurotransmitter metabolic process (GO:0042133) | 2.29074054 |
| 179 | retinal ganglion cell axon guidance (GO:0031290) | 2.28930989 |
| 180 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.28564908 |
| 181 | protein complex biogenesis (GO:0070271) | 2.28445137 |
| 182 | cell differentiation in spinal cord (GO:0021515) | 2.27015086 |
| 183 | regulation of gene silencing by RNA (GO:0060966) | 2.26495369 |
| 184 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.26495369 |
| 185 | regulation of gene silencing by miRNA (GO:0060964) | 2.26495369 |
| 186 | regulation of synapse maturation (GO:0090128) | 2.24846177 |
| 187 | benzene-containing compound metabolic process (GO:0042537) | 2.24401259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.22240843 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.66885320 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.73945943 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.70442660 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.63054065 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.61236371 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.35637459 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33117448 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.30010856 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.28045749 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.24437657 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.24437657 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24076350 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.23929410 |
| 15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21210181 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20545954 |
| 17 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.16984542 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10857870 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99900154 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.94195723 |
| 21 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.92202915 |
| 22 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.91020878 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.90692570 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.84461998 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.80062692 |
| 26 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78674199 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76055158 |
| 28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75571559 |
| 29 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.75369753 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74486038 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73936411 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69354394 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67770780 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67066816 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66749817 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.65356583 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60586533 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.51105627 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51055726 |
| 40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.50431449 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50429957 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50378109 |
| 43 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.46828319 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43267783 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42588251 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40890400 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40240989 |
| 48 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39981226 |
| 49 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37399531 |
| 50 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.36759100 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36140771 |
| 52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34422539 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33853874 |
| 54 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33683296 |
| 55 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32333096 |
| 56 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31903534 |
| 57 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31057360 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.30815766 |
| 59 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.27493488 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27481509 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.25540444 |
| 62 | AR_19668381_ChIP-Seq_PC3_Human | 1.25101327 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25089311 |
| 64 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24621253 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23428648 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22951016 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22783647 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22036174 |
| 69 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21880836 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20531550 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20446325 |
| 72 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20076429 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19838465 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19838465 |
| 75 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.18705436 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17454865 |
| 77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17400151 |
| 78 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15161350 |
| 79 | * ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14930939 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14690685 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12651586 |
| 82 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12547097 |
| 83 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11918333 |
| 84 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11243202 |
| 85 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11141230 |
| 86 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10926140 |
| 87 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10859037 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.10786301 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08716878 |
| 90 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08704779 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08120345 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07372348 |
| 93 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.06866160 |
| 94 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06388266 |
| 95 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04798828 |
| 96 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04374071 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04084444 |
| 98 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03785662 |
| 99 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03785662 |
| 100 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03754816 |
| 101 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03367042 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03253949 |
| 103 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.02328191 |
| 104 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.02328191 |
| 105 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01968326 |
| 106 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01754402 |
| 107 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.01317171 |
| 108 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01045035 |
| 109 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00822001 |
| 110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00527316 |
| 111 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00358094 |
| 112 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99992999 |
| 113 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99235825 |
| 114 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99188783 |
| 115 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98005502 |
| 116 | FUS_26573619_Chip-Seq_HEK293_Human | 0.97598866 |
| 117 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97597792 |
| 118 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97597792 |
| 119 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97136230 |
| 120 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97112409 |
| 121 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97077398 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97051282 |
| 123 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95090198 |
| 124 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95084611 |
| 125 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94310342 |
| 126 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94251595 |
| 127 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93946055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.11115363 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.53425785 |
| 3 | MP0003880_abnormal_central_pattern | 3.48728044 |
| 4 | MP0004270_analgesia | 3.37102202 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 2.91554085 |
| 6 | MP0009745_abnormal_behavioral_response | 2.83098823 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.77529967 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.76607608 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.68085259 |
| 10 | MP0009046_muscle_twitch | 2.64673692 |
| 11 | MP0002064_seizures | 2.64572426 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.47549826 |
| 13 | MP0003787_abnormal_imprinting | 2.47201230 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.32395387 |
| 15 | MP0002272_abnormal_nervous_system | 2.31521490 |
| 16 | MP0001486_abnormal_startle_reflex | 2.31426439 |
| 17 | MP0003646_muscle_fatigue | 2.31239663 |
| 18 | MP0010386_abnormal_urinary_bladder | 2.30993172 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.28865748 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.20485519 |
| 21 | MP0002102_abnormal_ear_morphology | 2.11992908 |
| 22 | MP0005646_abnormal_pituitary_gland | 2.04660685 |
| 23 | MP0005379_endocrine/exocrine_gland_phen | 2.00755253 |
| 24 | MP0008877_abnormal_DNA_methylation | 1.88005698 |
| 25 | MP0002822_catalepsy | 1.87017637 |
| 26 | MP0003122_maternal_imprinting | 1.84262474 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.83073273 |
| 28 | MP0003283_abnormal_digestive_organ | 1.80930620 |
| 29 | MP0005645_abnormal_hypothalamus_physiol | 1.79207907 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.79056647 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.78696672 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.78592061 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.78150337 |
| 34 | MP0001984_abnormal_olfaction | 1.74705750 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.72910044 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.70822716 |
| 37 | MP0001970_abnormal_pain_threshold | 1.66588257 |
| 38 | MP0004043_abnormal_pH_regulation | 1.65273621 |
| 39 | MP0008569_lethality_at_weaning | 1.62429926 |
| 40 | MP0003011_delayed_dark_adaptation | 1.59485655 |
| 41 | * MP0002693_abnormal_pancreas_physiology | 1.59153154 |
| 42 | MP0008872_abnormal_physiological_respon | 1.54368186 |
| 43 | MP0002736_abnormal_nociception_after | 1.52191108 |
| 44 | * MP0002184_abnormal_innervation | 1.51983775 |
| 45 | MP0004133_heterotaxia | 1.51662920 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.49968924 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.48576334 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.47373946 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.46808438 |
| 50 | MP0000778_abnormal_nervous_system | 1.46406292 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.46233920 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.45815768 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.43891333 |
| 54 | MP0008775_abnormal_heart_ventricle | 1.43465015 |
| 55 | MP0002160_abnormal_reproductive_system | 1.38981294 |
| 56 | * MP0001485_abnormal_pinna_reflex | 1.38447258 |
| 57 | MP0004130_abnormal_muscle_cell | 1.37962206 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.35695518 |
| 59 | MP0004924_abnormal_behavior | 1.35695518 |
| 60 | MP0002938_white_spotting | 1.33177462 |
| 61 | MP0003136_yellow_coat_color | 1.31279602 |
| 62 | MP0006276_abnormal_autonomic_nervous | 1.30611235 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.29949798 |
| 64 | MP0000955_abnormal_spinal_cord | 1.29450508 |
| 65 | MP0004811_abnormal_neuron_physiology | 1.29442432 |
| 66 | * MP0001944_abnormal_pancreas_morphology | 1.29432920 |
| 67 | MP0001188_hyperpigmentation | 1.29339818 |
| 68 | MP0000427_abnormal_hair_cycle | 1.26570939 |
| 69 | MP0000230_abnormal_systemic_arterial | 1.25271433 |
| 70 | * MP0002882_abnormal_neuron_morphology | 1.24007029 |
| 71 | MP0004858_abnormal_nervous_system | 1.23501879 |
| 72 | * MP0003879_abnormal_hair_cell | 1.22536238 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.21174329 |
| 74 | MP0004215_abnormal_myocardial_fiber | 1.20707336 |
| 75 | MP0002928_abnormal_bile_duct | 1.20705473 |
| 76 | MP0003633_abnormal_nervous_system | 1.19537648 |
| 77 | MP0004019_abnormal_vitamin_homeostasis | 1.18640140 |
| 78 | MP0001986_abnormal_taste_sensitivity | 1.18623087 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 1.17421167 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 1.17245939 |
| 81 | MP0004885_abnormal_endolymph | 1.14946740 |
| 82 | MP0004142_abnormal_muscle_tone | 1.13119026 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 1.12803204 |
| 84 | MP0005174_abnormal_tail_pigmentation | 1.11773564 |
| 85 | MP0005448_abnormal_energy_balance | 1.09864133 |
| 86 | MP0005389_reproductive_system_phenotype | 1.09307451 |
| 87 | MP0000678_abnormal_parathyroid_gland | 1.04237768 |
| 88 | MP0005535_abnormal_body_temperature | 1.03102023 |
| 89 | MP0004510_myositis | 1.01798534 |
| 90 | * MP0002229_neurodegeneration | 1.01280490 |
| 91 | * MP0000026_abnormal_inner_ear | 1.01100853 |
| 92 | MP0003045_fibrosis | 1.00903026 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00561730 |
| 94 | MP0000383_abnormal_hair_follicle | 0.98951126 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.96936485 |
| 96 | MP0003890_abnormal_embryonic-extraembry | 0.96922109 |
| 97 | MP0003329_amyloid_beta_deposits | 0.94868477 |
| 98 | MP0005195_abnormal_posterior_eye | 0.94373312 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.93863704 |
| 100 | MP0003938_abnormal_ear_development | 0.93310677 |
| 101 | MP0003119_abnormal_digestive_system | 0.92794530 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.92360571 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.91129305 |
| 104 | MP0003631_nervous_system_phenotype | 0.90845083 |
| 105 | MP0003878_abnormal_ear_physiology | 0.90094346 |
| 106 | MP0005377_hearing/vestibular/ear_phenot | 0.90094346 |
| 107 | MP0002152_abnormal_brain_morphology | 0.89962714 |
| 108 | MP0004742_abnormal_vestibular_system | 0.89640207 |
| 109 | MP0010329_abnormal_lipoprotein_level | 0.88368814 |
| 110 | * MP0004085_abnormal_heartbeat | 0.87036771 |
| 111 | MP0001905_abnormal_dopamine_level | 0.85287655 |
| 112 | * MP0002078_abnormal_glucose_homeostasis | 0.85092375 |
| 113 | MP0005253_abnormal_eye_physiology | 0.83571709 |
| 114 | MP0000049_abnormal_middle_ear | 0.82916251 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.82669624 |
| 116 | MP0002090_abnormal_vision | 0.79618447 |
| 117 | * MP0001765_abnormal_ion_homeostasis | 0.79222613 |
| 118 | MP0003634_abnormal_glial_cell | 0.79149920 |
| 119 | * MP0001963_abnormal_hearing_physiology | 0.77072776 |
| 120 | MP0002163_abnormal_gland_morphology | 0.76425401 |
| 121 | MP0005409_darkened_coat_color | 0.76282886 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.75697306 |
| 123 | MP0003195_calcinosis | 0.74734568 |
| 124 | MP0003121_genomic_imprinting | 0.74136267 |
| 125 | MP0001664_abnormal_digestion | 0.72560120 |
| 126 | MP0001177_atelectasis | 0.72127037 |
| 127 | MP0003690_abnormal_glial_cell | 0.70182051 |
| 128 | * MP0003953_abnormal_hormone_level | 0.69555436 |
| 129 | MP0005187_abnormal_penis_morphology | 0.69550470 |
| 130 | MP0005310_abnormal_salivary_gland | 0.64511676 |
| 131 | * MP0002752_abnormal_somatic_nervous | 0.63240599 |
| 132 | MP0001529_abnormal_vocalization | 0.62962476 |
| 133 | MP0001299_abnormal_eye_distance/ | 0.62383276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.98201305 |
| 2 | Visual hallucinations (HP:0002367) | 4.51629554 |
| 3 | Focal seizures (HP:0007359) | 4.50853343 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.41719847 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.37722500 |
| 6 | Pancreatic cysts (HP:0001737) | 4.00528174 |
| 7 | Febrile seizures (HP:0002373) | 3.93070441 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.89028602 |
| 9 | Molar tooth sign on MRI (HP:0002419) | 3.77175667 |
| 10 | Abnormality of midbrain morphology (HP:0002418) | 3.77175667 |
| 11 | Atonic seizures (HP:0010819) | 3.72519141 |
| 12 | Nephronophthisis (HP:0000090) | 3.64432301 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.63718627 |
| 14 | Myokymia (HP:0002411) | 3.61843385 |
| 15 | Congenital stationary night blindness (HP:0007642) | 3.60365757 |
| 16 | True hermaphroditism (HP:0010459) | 3.46848180 |
| 17 | Absence seizures (HP:0002121) | 3.42630839 |
| 18 | Abnormality of the renal cortex (HP:0011035) | 3.29232443 |
| 19 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.27245353 |
| 20 | Abolished electroretinogram (ERG) (HP:0000550) | 3.24710848 |
| 21 | Agitation (HP:0000713) | 3.21921729 |
| 22 | Abnormality of the renal medulla (HP:0100957) | 3.20665141 |
| 23 | Clumsiness (HP:0002312) | 3.19986846 |
| 24 | Dialeptic seizures (HP:0011146) | 3.19238587 |
| 25 | Epileptiform EEG discharges (HP:0011182) | 3.15479153 |
| 26 | EEG with generalized epileptiform discharges (HP:0011198) | 3.05054319 |
| 27 | Action tremor (HP:0002345) | 3.04936406 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 3.00430746 |
| 29 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.96190730 |
| 30 | Tubular atrophy (HP:0000092) | 2.94926759 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 2.93147003 |
| 32 | Broad-based gait (HP:0002136) | 2.92409183 |
| 33 | Excessive salivation (HP:0003781) | 2.90272606 |
| 34 | Drooling (HP:0002307) | 2.90272606 |
| 35 | Type II lissencephaly (HP:0007260) | 2.89511483 |
| 36 | * Generalized tonic-clonic seizures (HP:0002069) | 2.88018827 |
| 37 | Hyperventilation (HP:0002883) | 2.86408415 |
| 38 | Genetic anticipation (HP:0003743) | 2.85876078 |
| 39 | Hemiparesis (HP:0001269) | 2.84756116 |
| 40 | Hypsarrhythmia (HP:0002521) | 2.83797515 |
| 41 | Abnormal drinking behavior (HP:0030082) | 2.78854716 |
| 42 | Polydipsia (HP:0001959) | 2.78854716 |
| 43 | Cystic liver disease (HP:0006706) | 2.75966877 |
| 44 | Chronic hepatic failure (HP:0100626) | 2.70365412 |
| 45 | Truncal ataxia (HP:0002078) | 2.70148635 |
| 46 | Amblyopia (HP:0000646) | 2.66233773 |
| 47 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.64496438 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.61719641 |
| 49 | Retinal atrophy (HP:0001105) | 2.61177473 |
| 50 | Symptomatic seizures (HP:0011145) | 2.60919849 |
| 51 | Papilledema (HP:0001085) | 2.60113534 |
| 52 | Ankle clonus (HP:0011448) | 2.53595910 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.52744387 |
| 54 | Hyperkalemia (HP:0002153) | 2.52442973 |
| 55 | Attenuation of retinal blood vessels (HP:0007843) | 2.47723835 |
| 56 | Anxiety (HP:0000739) | 2.47573608 |
| 57 | Depression (HP:0000716) | 2.45368141 |
| 58 | Congenital sensorineural hearing impairment (HP:0008527) | 2.42356342 |
| 59 | Increased circulating renin level (HP:0000848) | 2.42227864 |
| 60 | Diplopia (HP:0000651) | 2.41797532 |
| 61 | Abnormality of binocular vision (HP:0011514) | 2.41797532 |
| 62 | Dysmetria (HP:0001310) | 2.37418494 |
| 63 | Inability to walk (HP:0002540) | 2.35817492 |
| 64 | Congenital, generalized hypertrichosis (HP:0004540) | 2.34248655 |
| 65 | Dysdiadochokinesis (HP:0002075) | 2.34246891 |
| 66 | Absent/shortened dynein arms (HP:0200106) | 2.30421306 |
| 67 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.30421306 |
| 68 | Absent speech (HP:0001344) | 2.30331569 |
| 69 | Decreased central vision (HP:0007663) | 2.28814303 |
| 70 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.28194016 |
| 71 | Abnormality of alanine metabolism (HP:0010916) | 2.27892407 |
| 72 | Hyperalaninemia (HP:0003348) | 2.27892407 |
| 73 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27892407 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.26060428 |
| 75 | Concave nail (HP:0001598) | 2.24298424 |
| 76 | * Decreased circulating renin level (HP:0003351) | 2.23643976 |
| 77 | Postural instability (HP:0002172) | 2.22364368 |
| 78 | Abnormal pancreas size (HP:0012094) | 2.21900523 |
| 79 | Hemiplegia (HP:0002301) | 2.20373001 |
| 80 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.19797170 |
| 81 | Renal cortical cysts (HP:0000803) | 2.19100071 |
| 82 | Furrowed tongue (HP:0000221) | 2.18091404 |
| 83 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18088446 |
| 84 | Sclerocornea (HP:0000647) | 2.17245667 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.15040270 |
| 86 | Protruding tongue (HP:0010808) | 2.10605684 |
| 87 | Abnormality of salivation (HP:0100755) | 2.09856984 |
| 88 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.09235425 |
| 89 | Keratoconus (HP:0000563) | 2.09007919 |
| 90 | Increased corneal curvature (HP:0100692) | 2.09007919 |
| 91 | Widely spaced teeth (HP:0000687) | 2.07603588 |
| 92 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.07009082 |
| 93 | Male pseudohermaphroditism (HP:0000037) | 2.06660167 |
| 94 | Prolonged QT interval (HP:0001657) | 2.06477684 |
| 95 | Polyuria (HP:0000103) | 2.06131333 |
| 96 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.05713850 |
| 97 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.04914201 |
| 98 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.04914201 |
| 99 | Abnormal ciliary motility (HP:0012262) | 2.04561985 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 2.03786518 |
| 101 | Bilateral microphthalmos (HP:0007633) | 2.03199905 |
| 102 | Blue irides (HP:0000635) | 2.03107091 |
| 103 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.02236883 |
| 104 | Poor eye contact (HP:0000817) | 2.01978487 |
| 105 | Ketosis (HP:0001946) | 2.01866973 |
| 106 | Patellar aplasia (HP:0006443) | 2.01424545 |
| 107 | Morphological abnormality of the middle ear (HP:0008609) | 2.00905382 |
| 108 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.99376325 |
| 109 | Nephrogenic diabetes insipidus (HP:0009806) | 1.98448061 |
| 110 | Abnormal eating behavior (HP:0100738) | 1.97197449 |
| 111 | Generalized hypopigmentation of hair (HP:0011358) | 1.95684639 |
| 112 | Congenital hepatic fibrosis (HP:0002612) | 1.95631082 |
| 113 | Pendular nystagmus (HP:0012043) | 1.95342239 |
| 114 | Genital tract atresia (HP:0001827) | 1.95029178 |
| 115 | Chorioretinal atrophy (HP:0000533) | 1.93866330 |
| 116 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.93428694 |
| 117 | Fibular aplasia (HP:0002990) | 1.92827482 |
| 118 | Gait imbalance (HP:0002141) | 1.92544190 |
| 119 | Tachypnea (HP:0002789) | 1.91579998 |
| 120 | Fibular hypoplasia (HP:0003038) | 1.91422033 |
| 121 | Vaginal atresia (HP:0000148) | 1.91373133 |
| 122 | Lissencephaly (HP:0001339) | 1.91288585 |
| 123 | Hypoplasia of the fovea (HP:0007750) | 1.90712244 |
| 124 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.90712244 |
| 125 | Hypoplasia of the pons (HP:0012110) | 1.90409823 |
| 126 | Abnormal social behavior (HP:0012433) | 1.87879821 |
| 127 | Impaired social interactions (HP:0000735) | 1.87879821 |
| 128 | Abnormal EKG (HP:0003115) | 1.87459876 |
| 129 | Large for gestational age (HP:0001520) | 1.87230664 |
| 130 | Abnormality of the renal collecting system (HP:0004742) | 1.86276933 |
| 131 | Abnormality of the pons (HP:0007361) | 1.86222284 |
| 132 | Intention tremor (HP:0002080) | 1.85764672 |
| 133 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.84462823 |
| 134 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.84462823 |
| 135 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.83944775 |
| 136 | Hypothermia (HP:0002045) | 1.83714940 |
| 137 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.83671596 |
| 138 | Abnormality of renal excretion (HP:0011036) | 1.83596187 |
| 139 | Progressive inability to walk (HP:0002505) | 1.81941644 |
| 140 | Spastic gait (HP:0002064) | 1.81709794 |
| 141 | Postural tremor (HP:0002174) | 1.81295522 |
| 142 | Stereotypic behavior (HP:0000733) | 1.81107276 |
| 143 | Bradykinesia (HP:0002067) | 1.80497927 |
| 144 | Hyperactive renin-angiotensin system (HP:0000841) | 1.80215963 |
| 145 | Exotropia (HP:0000577) | 1.79924412 |
| 146 | Psychosis (HP:0000709) | 1.79761706 |
| 147 | Syncope (HP:0001279) | 1.79573505 |
| 148 | Labial hypoplasia (HP:0000066) | 1.79566422 |
| 149 | Cerebellar dysplasia (HP:0007033) | 1.79215036 |
| 150 | Fair hair (HP:0002286) | 1.78744742 |
| 151 | Anencephaly (HP:0002323) | 1.77686788 |
| 152 | Methylmalonic acidemia (HP:0002912) | 1.77436631 |
| 153 | Ventricular fibrillation (HP:0001663) | 1.77032705 |
| 154 | Short tibia (HP:0005736) | 1.74490366 |
| 155 | Hyperglycemia (HP:0003074) | 1.74468643 |
| 156 | Limb dystonia (HP:0002451) | 1.74062935 |
| 157 | Abnormality of the nasal septum (HP:0000419) | 1.73892554 |
| 158 | Mesangial abnormality (HP:0001966) | 1.73032372 |
| 159 | Thyroid-stimulating hormone excess (HP:0002925) | 1.72884830 |
| 160 | Scanning speech (HP:0002168) | 1.72725339 |
| 161 | Mutism (HP:0002300) | 1.72611367 |
| 162 | Neuronal loss in central nervous system (HP:0002529) | 1.72385649 |
| 163 | Medial flaring of the eyebrow (HP:0010747) | 1.71605230 |
| 164 | Status epilepticus (HP:0002133) | 1.69875288 |
| 165 | Obstructive sleep apnea (HP:0002870) | 1.69826805 |
| 166 | Ketoacidosis (HP:0001993) | 1.69598704 |
| 167 | Macroorchidism (HP:0000053) | 1.68178997 |
| 168 | Gastroesophageal reflux (HP:0002020) | 1.66768583 |
| 169 | Lower limb muscle weakness (HP:0007340) | 1.65186173 |
| 170 | Intestinal atresia (HP:0011100) | 1.64361872 |
| 171 | Congenital primary aphakia (HP:0007707) | 1.64290834 |
| 172 | Megalencephaly (HP:0001355) | 1.64201487 |
| 173 | * Abnormality of potassium homeostasis (HP:0011042) | 1.63506598 |
| 174 | Neoplasm of the heart (HP:0100544) | 1.62476334 |
| 175 | Impaired vibratory sensation (HP:0002495) | 1.62110776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.98433022 |
| 2 | INSRR | 3.50624981 |
| 3 | EPHA4 | 3.14690789 |
| 4 | ADRBK2 | 2.98096397 |
| 5 | MAP3K9 | 2.71154182 |
| 6 | TLK1 | 2.68164485 |
| 7 | ACVR1B | 2.62206944 |
| 8 | GRK1 | 2.55043156 |
| 9 | MAP3K4 | 2.41830737 |
| 10 | MARK1 | 2.35330977 |
| 11 | PRKD3 | 2.31770006 |
| 12 | PINK1 | 2.15213124 |
| 13 | MAP2K7 | 2.10891504 |
| 14 | CASK | 2.10378057 |
| 15 | TNIK | 1.95398579 |
| 16 | NTRK2 | 1.77656011 |
| 17 | TAOK3 | 1.76795472 |
| 18 | DAPK2 | 1.75304123 |
| 19 | RIPK4 | 1.71486219 |
| 20 | MINK1 | 1.67745204 |
| 21 | MAP3K2 | 1.63879377 |
| 22 | MAPK13 | 1.60852402 |
| 23 | MAP4K2 | 1.57947108 |
| 24 | SIK2 | 1.57428578 |
| 25 | PAK6 | 1.55734039 |
| 26 | FGFR2 | 1.49881374 |
| 27 | CDC42BPA | 1.48091663 |
| 28 | MAPK15 | 1.44651390 |
| 29 | STK39 | 1.43979811 |
| 30 | NTRK1 | 1.42081276 |
| 31 | CAMKK2 | 1.37688685 |
| 32 | OXSR1 | 1.37099468 |
| 33 | CAMKK1 | 1.32426275 |
| 34 | UHMK1 | 1.30913906 |
| 35 | PRPF4B | 1.30060281 |
| 36 | CDK5 | 1.27166520 |
| 37 | PIK3CA | 1.26043542 |
| 38 | NUAK1 | 1.24983723 |
| 39 | ZAK | 1.23800849 |
| 40 | WNK3 | 1.22786393 |
| 41 | ADRBK1 | 1.19277106 |
| 42 | CAMK1G | 1.18226774 |
| 43 | HIPK2 | 1.17522187 |
| 44 | PRKCH | 1.16256945 |
| 45 | MAP2K4 | 1.14365554 |
| 46 | SGK2 | 1.13305745 |
| 47 | FES | 1.13138929 |
| 48 | GRK5 | 1.12520741 |
| 49 | BMPR2 | 1.10561079 |
| 50 | KSR2 | 1.09982292 |
| 51 | PNCK | 1.08347751 |
| 52 | PRKCG | 1.07983755 |
| 53 | SGK494 | 1.06810031 |
| 54 | SGK223 | 1.06810031 |
| 55 | MAP3K13 | 1.04228587 |
| 56 | MAP2K6 | 1.04141437 |
| 57 | FRK | 1.01410821 |
| 58 | CAMK2A | 0.98657764 |
| 59 | KSR1 | 0.97946670 |
| 60 | STK38 | 0.97364104 |
| 61 | WNK1 | 0.95979480 |
| 62 | PLK2 | 0.95381604 |
| 63 | MAPKAPK3 | 0.94207985 |
| 64 | STK38L | 0.93266506 |
| 65 | SGK3 | 0.92589391 |
| 66 | PAK3 | 0.91517420 |
| 67 | SGK1 | 0.91252938 |
| 68 | MARK2 | 0.91227896 |
| 69 | AKT3 | 0.91124848 |
| 70 | CAMK2B | 0.87585433 |
| 71 | PRKCE | 0.87445178 |
| 72 | CAMK1 | 0.85219967 |
| 73 | MAP3K1 | 0.82333464 |
| 74 | WNK4 | 0.81460098 |
| 75 | TRPM7 | 0.81342158 |
| 76 | DYRK1A | 0.81174827 |
| 77 | NLK | 0.80956035 |
| 78 | DAPK1 | 0.80701399 |
| 79 | DYRK2 | 0.78372158 |
| 80 | BCR | 0.77658843 |
| 81 | TIE1 | 0.77188196 |
| 82 | STK11 | 0.76395403 |
| 83 | MAPKAPK5 | 0.75567220 |
| 84 | PRKD2 | 0.75353253 |
| 85 | ERBB2 | 0.75331300 |
| 86 | CAMK2D | 0.73712974 |
| 87 | NEK6 | 0.69017675 |
| 88 | PRKAA2 | 0.68756158 |
| 89 | MKNK2 | 0.67830568 |
| 90 | OBSCN | 0.66876123 |
| 91 | PHKG1 | 0.64497900 |
| 92 | PHKG2 | 0.64497900 |
| 93 | RPS6KA6 | 0.64225225 |
| 94 | CSNK1G2 | 0.63881435 |
| 95 | SIK3 | 0.63570456 |
| 96 | TGFBR1 | 0.62865731 |
| 97 | FER | 0.62656160 |
| 98 | PKN1 | 0.62529711 |
| 99 | PTK2B | 0.59785294 |
| 100 | PRKAA1 | 0.58700025 |
| 101 | CDK3 | 0.58542392 |
| 102 | RPS6KA2 | 0.58106955 |
| 103 | CSNK1G1 | 0.57523243 |
| 104 | STK3 | 0.57463622 |
| 105 | RPS6KA3 | 0.56924987 |
| 106 | BMPR1B | 0.56274847 |
| 107 | PRKG1 | 0.56149590 |
| 108 | RET | 0.55890627 |
| 109 | MUSK | 0.54379107 |
| 110 | GRK7 | 0.54167917 |
| 111 | CAMK4 | 0.52748493 |
| 112 | DMPK | 0.52215067 |
| 113 | TXK | 0.52185736 |
| 114 | TNK2 | 0.51743101 |
| 115 | CHUK | 0.51728856 |
| 116 | CSNK1A1 | 0.49915777 |
| 117 | PRKCZ | 0.49132985 |
| 118 | IRAK2 | 0.47718721 |
| 119 | CAMK1D | 0.47411179 |
| 120 | ARAF | 0.46082285 |
| 121 | PASK | 0.45818671 |
| 122 | PDPK1 | 0.44908710 |
| 123 | CSNK1G3 | 0.44781705 |
| 124 | PRKACA | 0.43981160 |
| 125 | FYN | 0.43693089 |
| 126 | MAP2K2 | 0.42459426 |
| 127 | MAPK10 | 0.41541597 |
| 128 | PRKCI | 0.41400214 |
| 129 | PRKCB | 0.41193921 |
| 130 | RPS6KA5 | 0.40880768 |
| 131 | MAP2K1 | 0.40231501 |
| 132 | PTK2 | 0.39923797 |
| 133 | EPHA3 | 0.39838570 |
| 134 | PDK1 | 0.38944102 |
| 135 | RPS6KB1 | 0.38787346 |
| 136 | NME1 | 0.37935336 |
| 137 | NEK2 | 0.37529308 |
| 138 | PRKCA | 0.37410971 |
| 139 | MAP3K7 | 0.37141929 |
| 140 | FGR | 0.37129391 |
| 141 | CAMK2G | 0.36681127 |
| 142 | IRAK1 | 0.34506413 |
| 143 | PRKCQ | 0.33632101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.28820441 |
| 2 | * Insulin secretion_Homo sapiens_hsa04911 | 2.78261845 |
| 3 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.56623431 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.47930583 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.47295465 |
| 6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.46852644 |
| 7 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.45317460 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.38061489 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.37846077 |
| 10 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35759091 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.31239368 |
| 12 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.26467555 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.24104938 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.21611180 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.16431698 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14020306 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.01822523 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99325867 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.95993290 |
| 20 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 1.95487904 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94270829 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.90378527 |
| 23 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.83998604 |
| 24 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80314370 |
| 25 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.78898908 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.77365631 |
| 27 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.75657788 |
| 28 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.71382426 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62167203 |
| 30 | * Renin secretion_Homo sapiens_hsa04924 | 1.60867266 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.58247229 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50657939 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.50542279 |
| 34 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49292056 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47854510 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.46889907 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.45713269 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41422451 |
| 39 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.38376585 |
| 40 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37688524 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.35757241 |
| 42 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.34485872 |
| 43 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31710499 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29541082 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26813156 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26688656 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25732013 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25029838 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.24650627 |
| 50 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19297268 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16499704 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15687566 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15431844 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.15332734 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15097441 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14484415 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14396561 |
| 58 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11629878 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11524933 |
| 60 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10752352 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.10059527 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 1.09971365 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09599136 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06177754 |
| 65 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.03930724 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03382718 |
| 67 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.03020641 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01624718 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 1.01237035 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00540626 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96814048 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94875839 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.92605512 |
| 74 | Melanogenesis_Homo sapiens_hsa04916 | 0.92041161 |
| 75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91284405 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88989882 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88184181 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87549717 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82820284 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81367761 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80586923 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80142516 |
| 83 | Axon guidance_Homo sapiens_hsa04360 | 0.79729663 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76828822 |
| 85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76595268 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74795954 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73793588 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73209775 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.71689266 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70807995 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67477204 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67033584 |
| 93 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66994036 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66080152 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64788716 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64337172 |
| 97 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63196120 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62680692 |
| 99 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59750836 |
| 100 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59650169 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57393044 |
| 102 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.57002867 |
| 103 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56193843 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.56171611 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55991092 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55383686 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54019371 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53405662 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53161581 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52717319 |
| 111 | Protein export_Homo sapiens_hsa03060 | 0.51124994 |
| 112 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.51017864 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50361965 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49012360 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48946400 |
| 116 | Lysosome_Homo sapiens_hsa04142 | 0.48574106 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48205334 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45935347 |
| 119 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44995974 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44335413 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44221131 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43785249 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43640551 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43603657 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43525893 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42525153 |
| 127 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42040639 |
| 128 | Alcoholism_Homo sapiens_hsa05034 | 0.40679986 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38469138 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.37229268 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36552857 |
| 132 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35411206 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35270226 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35094149 |
| 135 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34388679 |
| 136 | Homologous recombination_Homo sapiens_hsa03440 | 0.34101719 |
| 137 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33578837 |
| 138 | RNA polymerase_Homo sapiens_hsa03020 | 0.33241366 |
| 139 | Insulin resistance_Homo sapiens_hsa04931 | 0.32740858 |
| 140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32702861 |
| 141 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32157709 |
| 142 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.31860575 |
| 143 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30274285 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.30165525 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30106854 |
| 146 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29565316 |
| 147 | Endocytosis_Homo sapiens_hsa04144 | 0.29401690 |
| 148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28914277 |
| 149 | ABC transporters_Homo sapiens_hsa02010 | 0.27530639 |

